Radiographic patterns of relapse in glioblastoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-01

AUTHORS

Marc C. Chamberlain

ABSTRACT

Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab. More... »

PAGES

319-323

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4

DOI

http://dx.doi.org/10.1007/s11060-010-0251-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011002727

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21052776


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Washington", 
          "id": "https://www.grid.ac/institutes/grid.34477.33", 
          "name": [
            "Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Research Cancer Center, University of Washington, 895 Eastlake Ave, POB Box 19023, MS-G4-940, 98109-1023, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2007.12.2440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008387745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.3055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010751135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2009-006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011570339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.10.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038799886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.8721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042965400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00146880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046803627", 
          "https://doi.org/10.1007/bf00146880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00146880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046803627", 
          "https://doi.org/10.1007/bf00146880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-01", 
    "datePublishedReg": "2011-01-01", 
    "description": "Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-010-0251-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "name": "Radiographic patterns of relapse in glioblastoma", 
    "pagination": "319-323", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "346bf36d52242c9a96adb1e218e0334c6e1fa029b1ed987181faf064c873146b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21052776"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-010-0251-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011002727"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-010-0251-4", 
      "https://app.dimensions.ai/details/publication/pub.1011002727"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113670_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-010-0251-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      21 PREDICATES      60 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-010-0251-4 schema:about N0453070853f247ffb04bc5d6b73a0641
2 N0e57a3de94254a569e6b8b7857b4b890
3 N2e523b1c10c944cd9a0612adb7438526
4 N32ad587a4fb34aa69ce314ad79b3acae
5 N32b404ab084d4438a63b629a968a5ce8
6 N32e704566e6448a1a0d5fc4fd6f06243
7 N3b53d69c7ae44a988c26bdaf6de47830
8 N4c3670e69abb4048a0f1808205b41d81
9 N5defb29cd76547b7a7d038f5ce9a063a
10 N7b11a2b544dd4f5ab876535a417ac4cc
11 N8d85a3ea3b7f4bbeac0e8951d358818a
12 N9bdea720df2d4dc5a0215ee62b53ce51
13 Na560a9e13df142d5b204e5e31c783da9
14 Naa7a0f89d2274ceabfc76884b17a6eac
15 Nb7995d78c60245adb4ad0e3ed1877d02
16 Nb9141110940a4b3f82764e5b4cc5659d
17 Nc3e3d4cfe9234acfa8b0a3da76a47fb8
18 Ncca892498faa444f97f196be0d70abad
19 Nef14064f6086411895b2b60e337a9d99
20 Nf1a15d8c62a14588bde0fd0e7b627eca
21 Nf402c501c25f4827a1338ebcf80f9928
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N2568677a37744f28befdd9c83596ad2b
25 schema:citation sg:pub.10.1007/bf00146880
26 https://doi.org/10.1016/j.ijrobp.2008.10.043
27 https://doi.org/10.1056/nejmoa043330
28 https://doi.org/10.1200/jco.2007.12.2440
29 https://doi.org/10.1200/jco.2008.16.3055
30 https://doi.org/10.1200/jco.2008.19.8721
31 https://doi.org/10.1200/jco.2009.26.3541
32 https://doi.org/10.1212/01.wnl.0000304121.57857.38
33 https://doi.org/10.1212/wnl.0b013e3181bc0184
34 https://doi.org/10.1215/15228517-2009-006
35 schema:datePublished 2011-01
36 schema:datePublishedReg 2011-01-01
37 schema:description Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N597b661906ec4322b1fc86142b12a220
42 Nd32ee19dcf624ccb944fa708fd40227f
43 sg:journal.1094205
44 schema:name Radiographic patterns of relapse in glioblastoma
45 schema:pagination 319-323
46 schema:productId N07720ba5bfb049779a9e89ac779a11ec
47 N1b8ec8d5e66e470398eae83a6d7c3c3d
48 N1c9e039b7db14d51a3f350a89c181afe
49 N29fc8a376f2b440b882a3e3975471e0c
50 Ne6ecfd6af06a4a15b97b6b1eb9e135e9
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011002727
52 https://doi.org/10.1007/s11060-010-0251-4
53 schema:sdDatePublished 2019-04-11T10:35
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N23ac3bc693494daf850a6afd0c37ea72
56 schema:url http://link.springer.com/10.1007%2Fs11060-010-0251-4
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N0453070853f247ffb04bc5d6b73a0641 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Neoplasm Recurrence, Local
62 rdf:type schema:DefinedTerm
63 N07720ba5bfb049779a9e89ac779a11ec schema:name nlm_unique_id
64 schema:value 8309335
65 rdf:type schema:PropertyValue
66 N0e57a3de94254a569e6b8b7857b4b890 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Young Adult
68 rdf:type schema:DefinedTerm
69 N1b8ec8d5e66e470398eae83a6d7c3c3d schema:name doi
70 schema:value 10.1007/s11060-010-0251-4
71 rdf:type schema:PropertyValue
72 N1c9e039b7db14d51a3f350a89c181afe schema:name dimensions_id
73 schema:value pub.1011002727
74 rdf:type schema:PropertyValue
75 N23ac3bc693494daf850a6afd0c37ea72 schema:name Springer Nature - SN SciGraph project
76 rdf:type schema:Organization
77 N2568677a37744f28befdd9c83596ad2b rdf:first sg:person.01326261166.36
78 rdf:rest rdf:nil
79 N29fc8a376f2b440b882a3e3975471e0c schema:name readcube_id
80 schema:value 346bf36d52242c9a96adb1e218e0334c6e1fa029b1ed987181faf064c873146b
81 rdf:type schema:PropertyValue
82 N2e523b1c10c944cd9a0612adb7438526 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Combined Modality Therapy
84 rdf:type schema:DefinedTerm
85 N32ad587a4fb34aa69ce314ad79b3acae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Salvage Therapy
87 rdf:type schema:DefinedTerm
88 N32b404ab084d4438a63b629a968a5ce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Magnetic Resonance Imaging
90 rdf:type schema:DefinedTerm
91 N32e704566e6448a1a0d5fc4fd6f06243 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 N3b53d69c7ae44a988c26bdaf6de47830 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Brain Neoplasms
96 rdf:type schema:DefinedTerm
97 N4c3670e69abb4048a0f1808205b41d81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 N597b661906ec4322b1fc86142b12a220 schema:volumeNumber 101
101 rdf:type schema:PublicationVolume
102 N5defb29cd76547b7a7d038f5ce9a063a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Female
104 rdf:type schema:DefinedTerm
105 N7b11a2b544dd4f5ab876535a417ac4cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Glioblastoma
107 rdf:type schema:DefinedTerm
108 N8d85a3ea3b7f4bbeac0e8951d358818a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Antineoplastic Agents
110 rdf:type schema:DefinedTerm
111 N9bdea720df2d4dc5a0215ee62b53ce51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Time Factors
113 rdf:type schema:DefinedTerm
114 Na560a9e13df142d5b204e5e31c783da9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Aged
116 rdf:type schema:DefinedTerm
117 Naa7a0f89d2274ceabfc76884b17a6eac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Adult
119 rdf:type schema:DefinedTerm
120 Nb7995d78c60245adb4ad0e3ed1877d02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Antineoplastic Agents, Alkylating
122 rdf:type schema:DefinedTerm
123 Nb9141110940a4b3f82764e5b4cc5659d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Radiography
125 rdf:type schema:DefinedTerm
126 Nc3e3d4cfe9234acfa8b0a3da76a47fb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Treatment Outcome
128 rdf:type schema:DefinedTerm
129 Ncca892498faa444f97f196be0d70abad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Retrospective Studies
131 rdf:type schema:DefinedTerm
132 Nd32ee19dcf624ccb944fa708fd40227f schema:issueNumber 2
133 rdf:type schema:PublicationIssue
134 Ne6ecfd6af06a4a15b97b6b1eb9e135e9 schema:name pubmed_id
135 schema:value 21052776
136 rdf:type schema:PropertyValue
137 Nef14064f6086411895b2b60e337a9d99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Temozolomide
139 rdf:type schema:DefinedTerm
140 Nf1a15d8c62a14588bde0fd0e7b627eca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Dacarbazine
142 rdf:type schema:DefinedTerm
143 Nf402c501c25f4827a1338ebcf80f9928 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
150 schema:name Oncology and Carcinogenesis
151 rdf:type schema:DefinedTerm
152 sg:journal.1094205 schema:issn 0167-594X
153 1573-7373
154 schema:name Journal of Neuro-Oncology
155 rdf:type schema:Periodical
156 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.34477.33
157 schema:familyName Chamberlain
158 schema:givenName Marc C.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
160 rdf:type schema:Person
161 sg:pub.10.1007/bf00146880 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046803627
162 https://doi.org/10.1007/bf00146880
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.ijrobp.2008.10.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038799886
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1200/jco.2007.12.2440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008387745
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1200/jco.2008.16.3055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010751135
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1200/jco.2008.19.8721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042965400
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1200/jco.2009.26.3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187529
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1212/01.wnl.0000304121.57857.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064350042
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1212/wnl.0b013e3181bc0184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354676
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1215/15228517-2009-006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011570339
181 rdf:type schema:CreativeWork
182 https://www.grid.ac/institutes/grid.34477.33 schema:alternateName University of Washington
183 schema:name Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Research Cancer Center, University of Washington, 895 Eastlake Ave, POB Box 19023, MS-G4-940, 98109-1023, Seattle, WA, USA
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...